MBII - Marrone Bio Innovations Inc. (MBII) CEO Kevin Helash on Q4 2021 Results - Earnings Call Transcript
Marrone Bio Innovations, Inc. (MBII) Q4 2021 Results Conference Call March 28, 2022 4:30 PM ET Company Participants Linda Moore - Chief Legal Officer Kevin Helash - Chief Executive Officer LaDon Johnson - Interim CFO Matti Tiainen - Senior Vice President of International Sales Kamal El Mernissi - Senior Director of Product & Marketing Conference Call Participants Bobby Burleson - Canaccord Dmitry Silversteyn - Water Tower Research Presentation Operator Good day, ladies and gentlemen. Thank you for standing by. Welcome to the Marrone Bio Innovations Conference Call Fourth Quarter and Full Year 2021 Earnings Conference. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today’s conference maybe recorded. [Operator Instructions] I would now like to hand the conference over to your speaker, Linda Moore, General Counsel. Please go ahead. Linda Moore Good afternoon,
For further details see:
Marrone Bio Innovations, Inc. (MBII) CEO Kevin Helash on Q4 2021 Results - Earnings Call Transcript